Document is current
Any future updates will be listed below
-
Authors
Silginer, Manuela https://orcid.org/0000-0003-2538-1244
Papa, Eleanna
Szabó, Emese
Vasella, Flavio
Pruschy, Martin
Stroh, Christopher
Roth, Patrick
Weiss, Tobias
Weller, Michael
-
Funding
Funding for this research was provided by:
San Salvatore Foundation
University of Zurich
Merck KGaA
- License Information
-
More Information
Article History
Received: 30 November 2022
Accepted: 5 February 2023
First Online: 13 March 2023
Declarations
:
: All animal experiments were conducted in accordance with the Swiss Cantonal Veterinary Office and according to guidelines of the Swiss federal law on animal protection and have been approved by the cantonal veterinary office.
: Not applicable.
: MS, EP, ES, FV and MP report no conflicts of interest. TW has received grant support and honoraria for consulting Philogen. PR has received research grants from MSD and Novocure and honoraria for advisory board participation or lectures from Bristol-Myers Squibb, Covagen, Debiopharm, Medac, MSD, Novartis, Novocure, QED, Roche and Virometix. MW has received research grants from Apogenix, Merck, Sharp & Dohme (MSD), Merck Healthcare KGaA and Quercis, and honoraria for lectures or advisory board participation or consulting from Adastra, Bristol Meyer Squibb (BMS), Medac, Merck, Sharp & Dohme (MSD), Merck Healthcare KGaA, Nerviano Medical Sciences, Novartis, Orbus, Philogen and y-Mabs.
